<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
    <channel>
        <title>eMedical Dermatology Review</title>
        <description>Conversations with key opinion leaders in the field of dermatology. 
</description>
        <link>http://www.hopkinscme.net/ofp/eMedDermReview/</link>
        <category>Science &amp; Medicine</category>
        <copyright>2007 JHUSOM, IJHN and eMedical Dermatology Review</copyright>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <language>en-us</language>
        <lastBuildDate>Wed, 21 Jul 2010 00:47:09 -0400</lastBuildDate>
        <pubDate>Wed, 21 Jul 2010 00:42:10 -0400</pubDate>
        <generator>FeedForAll Mac v2.1 (2.1.0.1); http://www.FeedForAll.com/</generator>
        <itunes:subtitle>Conversations with key opinion leaders in the field of dermatology.  
</itunes:subtitle>
        <itunes:summary>Conversations with key opinion leaders in the field of dermatology. eMedical Dermatology Review is a monthly CE accredited email and bi-monthly accredited podcast created specifically for dermatology professionals.  Each newsletter provides a review of important journal literature. The program is presented by the Johns Hopkins University School of Medicine, the Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy. eMedical Dermatology Review is supported by an educational grant from Centocor, Inc.</itunes:summary>
        <itunes:category text="Science &amp; Medicine"/>
        <itunes:keywords>edermatology, emeddem, ederm, Medicine, Health, Continuing Medical Education, CME, Dermatology, Nursing, Johns Hopkins University</itunes:keywords>
        <itunes:author>eMedical Dermatology Review</itunes:author>
        <itunes:owner>
            <itunes:email>news@johnshopkins.6cp.com</itunes:email>
            <itunes:name>eMedical Dermatology Review</itunes:name>
        </itunes:owner>
        <itunes:image href="http://www.dkbmedstream.com/podcast/emeddermatology/edermatology.jpg" />
        <itunes:explicit>no</itunes:explicit>
        <image>
            <url>http://www.dkbmedstream.com/podcast/emeddermatology/edermatology.jpg</url>
            <title>eMedical Dermatology Review</title>
            <link>http://www.hopkinscme.net/ofp/eMedDermReview/</link>
            <description>Conversations with key opinion leaders in the field of Dermatology.  
</description>
            <width>144</width>
            <height>144</height>
        </image>
        <item>
            <title>eMedicalDermatology Review: Collagen vascular disease</title>
            <description>The eMedicalDermatology Review podcast is a clinical discussion by our June author, Jeffrey P. Callen, MD on the topic of collagen vascular disease.  Highlights include the description of the cutaneous manifestations of collagen vascular diseases, ways to design an evaluation for a patient with a possible collagen vascular disease, and, defining a plan for the management of collagen vascular disease.</description>
            <link>http://www.emeddermreview.org</link>
            <author>mcades@gmail.com</author>
            <category  domain="Medicine">Science and Medicine</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/June_2010_eMedDerm_podcast.mp3" length="33756796" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">2EECA018-2DBA-4AF2-BC3B-AABD1BE74A0D-406-000006C438656D5D-FFA</guid>
            <pubDate>Wed, 21 Jul 2010 00:47:01 -0400</pubDate>
            <itunes:subtitle>A clinical discussion by Jeffrey P. Callen, MD on the topic of collagen vascular disease.</itunes:subtitle>
            <itunes:summary>On the topic of collagen vascular disease, Jeffrey P. Callen, MD, professor of Medicine in Dermatology, and Chief of the Division of Dermatology at the University of Louisville School of Medicine in Louisville Kentucky, will discuss the relationship of dermatomyositis to malignancy, the recognition of drugs as a cause of cutaneous lupus erythematosus, the diagnosis and management of lupus tumidus, and the recognition of drug induced hypersensitivity syndrome in a patient with rheumatoid arthritis.  From this discussion the objectives are to describe the cutaneous manifestations of collagen vascular diseases, design an evaluation for a patient with a possible collagen vascular disease, and, define a plan for the management of collagen vascular disease.</itunes:summary>
            <itunes:duration>28:08</itunes:duration>
            <itunes:keywords>Drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, corticosteroids, dermal plaques, Lupus erythematosus tumidus, dermal perivascular lymphocytic infiltrate, periappendegeal lymphocytic infiltrate, hydrochlorothiazid</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedicalDermatology Review: Dermatologic Fillers</title>
            <description>Drs. Jenny Kim and Jamie E. McInturff discusses the safety and efficacy of fillers: hyaluronic acid, calcium hydroxylapatite, and poly-L-lactic acid, and offer recommendations for avoiding and managing potential complications that may arise from their use.</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category>Science and Medicine</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/eMDmarch2010_3_22.mp3" length="38852482" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">C1EFD1A6-B499-4121-B1C3-88F1A00221F2-181-00000062E7BE160C-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:22:11 -0400</pubDate>
            <itunes:subtitle>Drs. Jenny Kim and Jamie E. McInturff discusses the safety and efficacy of fillers: hyaluronic acid, calcium hydroxylapatite and poly-L-lactic acid, and offer recommendations for avoiding and managing potential complications that may arise from their use.</itunes:subtitle>
            <itunes:summary>Jenny Kim, MD, Associate Professor of clinical medicine in the division of dermatology, and Jamie McInturff, MD, a third-year resident in the division of dermatology, both at the David Geffen School of Medicine at UCLA address the cosmetic needs of a patient with HIV and significant facial lipoatrophy, describe how particular fillers are more suited for use in particular facial regions, and detail the side-effects and how to manage complications of filler use.</itunes:summary>
            <itunes:duration>32:23</itunes:duration>
            <itunes:keywords>facial lipoatrophy, fillers, complications of filler, HIV lipoatrophy, Poly-L-lactic acid, Calcium hydroxylapatite, Autologous fat transfer, subcutaneous papule formation, facial rejuvenation, dynamic ryetids, Hyaluronic acid gels, volumizing, Bioengineer</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: Atopic Dermatitis – A Disease Caused by a Barrier Defect?</title>
            <description>A clinical discussion of Atopic Dermatitis - A Disease Caused by a Barrier Defect?</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/December08_eMedDerm.mp3" length="30" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">8C1DFD36-9043-4960-A155-8493110A9F72-365-00000737767F6FF3-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:20:36 -0400</pubDate>
            <itunes:subtitle>A clinical discussion of Atopic Dermatitis - A Disease Caused by a Barrier Defect?</itunes:subtitle>
            <itunes:summary>The eMedicalDermatology Review podcast is a clinical discussion between our December author, Lisa Beck, MD, Susan Rabizadeh, eMedDerm Program Director and Robert Busker, eMedicalDermatology Review's Medical Editor. The topic is Atopic Dermatitis - A Disease Caused by a Barrier Defect?</itunes:summary>
            <itunes:duration>23:46</itunes:duration>
            <itunes:keywords>skin, barrier, defect, Atopic, Dermatitis, enzymatically-active, allergens</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: Acne Update</title>
            <description>A clinical discussion of an Acne Update.  Go to www.emeddermreview.org for more information.</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/October_08_eMedDerm_podcast.mp3" length="30" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">0919DEE4-C979-4825-919F-83A144712481-365-0000074758ED00E8-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:20:41 -0400</pubDate>
            <itunes:subtitle>A clinical discussion of an Acne Update.  Go to www.emeddermreview.org for more information.</itunes:subtitle>
            <itunes:summary>The eMedicalDermatology Review podcast is a clinical discussion between our October author, James Q. Del Rosso, DO and Robert Busker, eMedicalDermatology Review's Medical Editor. The topic is Acne Update. Participants receive 0.5 credits per podcast after completing an online post-test. Go to www.emeddermreview.org for more information.</itunes:summary>
            <itunes:duration>30:46</itunes:duration>
            <itunes:keywords>combination, topical, therapy, acne, vulgaris, contraceptive</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: Melanoma-Sentinel Lymph Node Biops</title>
            <description>A clinical discussion of Sentinel Lymph Node Biopsies.  Go to www.emeddermreview.org for more information.</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/April_2008_eMedDerm_podcast.mp3" length="30" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">57A85EBB-A04B-417B-B8EE-2154F50EDF11-365-0000075C58D35E0F-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:20:47 -0400</pubDate>
            <itunes:subtitle>A clinical discussion of Sentinel Lymph Node Biopsies.  Go to www.emeddermreview.org for more information.</itunes:subtitle>
            <itunes:summary>The eMedicalDermatology Review podcast is a clinical discussion between our April authors, Julie Lange, MD, Matthew Hueman, MD, Susan Rabizadeh, MD, and Robert Busker, eMedicalDermatology Review's Medical Editor. The topic is Sentinel Lymph Node Biopsies. Participants receive 0.5 credits per podcast after completing an online post-test. Go to www.emeddermreview.org for more information</itunes:summary>
            <itunes:duration>30:46</itunes:duration>
            <itunes:keywords>sentinel, node, biopsy, clinical, melanoma</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: Topical Therapy of Psoriasis</title>
            <description>A discussion of Topical Therapy of Psoriasis. Go to www.emeddermreview.org for more information</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/February_2008_eMedDerm.mp3" length="30" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">F0DE002A-AE7E-45FC-AD02-CDF48C196ADC-365-000007695CFFE593-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:20:51 -0400</pubDate>
            <itunes:subtitle>A discussion of Topical Therapy of Psoriasis. Go to www.emeddermreview.org for more information</itunes:subtitle>
            <itunes:summary>The eMedicalDermatology Review podcast is a discussion between our February authors, Steve Feldman, MD, Dan Pearce, MD and Robert Busker, eMedicalDermatology Review's Medical Editor. The topic is Topical Therapy of Psoriasis. Participants receive 0.5 credits per podcast after completing an online post-test. Go to www.emeddermreview.org for more information</itunes:summary>
            <itunes:duration>30:15</itunes:duration>
            <itunes:keywords>ointment, cream medications, tachyphylaxis, compliance</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: Community-Acquired Methicillin-Resistant S. aureus (CA-MRSA) Skin And Soft Tissue Infections</title>
            <description>A discussion on the differences between community-acquired MRSA and healthcare-associated MRSA, antibiotic options for CA-MRSA skin infections, and the management of patients with recurrent MRSA skin infections.</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/December_07_eMedDerm.mp3" length="30" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">E02E1F8C-B6A6-47A7-9423-3B40B9889B00-365-000007775F42158E-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:20:57 -0400</pubDate>
            <itunes:subtitle>A discussion on the differences between community-acquired MRSA and healthcare-associated MRSA, antibiotic options for CA-MRSA skin infections, and the management of patients with recurrent MRSA skin infections.</itunes:subtitle>
            <itunes:summary>The eMedicalDermatology Review podcast is a discussion between our December author, Sara Cosgrove, MD and Robert Busker, eMedicalDermatology Review's Medical Editor. The topics include: the differences between community-acquired MRSA and healthcare-associated MRSA, antibiotic options for CA-MRSA skin infections in which antibiotics are needed and the management of patients with recurrent MRSA skin infections.</itunes:summary>
            <itunes:duration>29:56</itunes:duration>
            <itunes:keywords>Community-acquired, S. aureus, skin, soft tissue</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: Ulcerated Hemangiomas of Infancy: Risk Factors and Management Strategies</title>
            <description>A discussion of ulcerated hemangiomas: recognizing risk factors and designing a management algorithm.</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/October07_eMedDerm.mp3" length="25" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">C0EDAE42-FB57-458A-96A1-1D0A2169B29C-365-000007867EB71E6F-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:21:01 -0400</pubDate>
            <itunes:subtitle>A discussion of ulcerated hemangiomas: recognizing risk factors and designing a management algorithm.</itunes:subtitle>
            <itunes:summary>The eMedicalDermatology Review podcast is a discussion between our October author, Bernard Cohen, MD and Robert Busker, eMedicalDermatology Review's Medical Editor. The topic is ulcerated hemangiomas: recognizing risk factors and designing a management algorithm.</itunes:summary>
            <itunes:duration>24:42</itunes:duration>
            <itunes:keywords>complications, ulcerations, anatomic</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

        <item>
            <title>eMedical Dermatology Review: New Developments in Biologic Therapy for Psoriasis</title>
            <description>Discuss five biologic therapies that have been introduced for the treatment of psoriasis or psoriatic arthritis, including side effects.</description>
            <link>http://www.emeddermreview.org</link>
            <author>news@johnshopkins.6cp.com (eMedical Dermatology Review)</author>
            <category  domain="Medicine">Science</category>
            <enclosure url="http://www.dkbmedstream.com/podcast/emeddermatology/June07_eMedicalDermatology_Review.mp3" length="27" type="audio/mpeg"  ></enclosure>
            <guid isPermaLink="false">B5E3762E-E746-4D97-A54B-A4C0BCF0FAB1-365-00000797B4AF2076-FFA</guid>
            <pubDate>Tue, 30 Mar 2010 14:21:08 -0400</pubDate>
            <itunes:subtitle>Discuss five biologic therapies that have been introduced for the treatment of psoriasis or psoriatic arthritis, including side effects.</itunes:subtitle>
            <itunes:summary>Patients with psoriasis and also presenting with concomitant conditions require consideration of safety issues, especially when presenting Hepatitis-C, tuberculosis, Multiple Sclerosis, Lupus, cancer or congestive heart failure.</itunes:summary>
            <itunes:duration>26:33</itunes:duration>
            <itunes:keywords>anti IL-12/23, TNF-α blockers, switched, nephrotoxicity</itunes:keywords>
            <itunes:author>eMedical Dermatology Review</itunes:author>
            <itunes:explicit>no</itunes:explicit>
        </item>

    </channel>
</rss>
